About Royalty Pharma
Royalty Pharma is a company based in New York (United States) founded in 1996 by Rory Riggs and Pablo Legorreta.. The company has 99 employees as of December 31, 2024. Royalty Pharma has completed 4 acquisitions, including Cypress Bioscience, Emgality and Minerva Neurosciences. Royalty Pharma offers products and services including Royalty Acquisitions and Funding Solutions.
- Headquarter New York, United States
- Employees 99 as on 31 Dec, 2024
- Founders Rory Riggs, Pablo Legorreta
- Stage Public
-
Sectors
Financial Services
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Royalty Pharma Plc
-
Annual Revenue
$2.26 B-3.86as on Dec 31, 2024
-
Net Profit
$858.98 M-24.31as on Dec 31, 2024
-
EBITDA
$1.29 B-13.38as on Dec 31, 2024
-
Latest Funding Round
- Investors
-
Employee Count
99
as on Dec 31, 2024
-
Investments & Acquisitions
Cypress Bioscience
& 3 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Royalty Pharma
Royalty Pharma is a publicly listed company on the NASDAQ with ticker symbol RPRX in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Royalty Pharma
Royalty Pharma offers a comprehensive portfolio of products and services, including Royalty Acquisitions and Funding Solutions. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Biopharmaceutical royalties are acquired by Royalty Pharma to support funding in life sciences
Tailored funding solutions are provided by Royalty Pharma for innovation in biotechnology and pharmaceuticals
Unlock access to complete
Unlock access to complete
Funding Insights of Royalty Pharma
- Total Funding Total Funding
- Total Rounds 1
- Last Round Last Round
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2020 | Amount | Private Equity Round - Royalty Pharma | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Royalty Pharma
Royalty Pharma has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include General Atlantic. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity fund focused on global markets
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Royalty Pharma
Royalty Pharma has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Cypress Bioscience, Emgality and Minerva Neurosciences. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Patient healthcare services are provided to support individual well-being.
|
2016 | ||||
|
Therapeutics for rare and ultra-rare metabolic diseases are developed.
|
2010 | ||||
|
Developing drugs against Psychiatric and other CNS Diseases
|
2007 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Royalty Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Royalty Pharma Comparisons
Competitors of Royalty Pharma
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Royalty Pharma
Frequently Asked Questions about Royalty Pharma
When was Royalty Pharma founded?
Royalty Pharma was founded in 1996 and raised its 1st funding round 24 years after it was founded.
Where is Royalty Pharma located?
Royalty Pharma is headquartered in New York, United States. It is registered at New York, New York, United States.
Who is the current CEO of Royalty Pharma?
Pablo Legorreta is the current CEO of Royalty Pharma. They have also founded this company.
How many employees does Royalty Pharma have?
As of Dec 31, 2024, the latest employee count at Royalty Pharma is 99.
What is the annual revenue of Royalty Pharma?
Annual revenue of Royalty Pharma is $2.26B as on Dec 31, 2024.
What does Royalty Pharma do?
Royalty Pharma was founded in 1996 in New York, United States, and operates as a private equity firm focused on biopharmaceutical investments. Royalties and stakes in marketed and late-stage products are acquired to support development and commercialization. In 2022, annual revenues of 2.24 billion were achieved, with net profit at 0.04 billion. Operations span global biopharma sectors, led by executives including co-founders Pablo Legorreta and Rory Riggs.
What products or services does Royalty Pharma offer?
Royalty Pharma offers Royalty Acquisitions and Funding Solutions.
Is Royalty Pharma publicly traded?
Yes, Royalty Pharma is publicly traded on NASDAQ under the ticker symbol RPRX.
How many acquisitions has Royalty Pharma made?
Royalty Pharma has made 4 acquisitions, including Cypress Bioscience, Emgality, and Minerva Neurosciences.
Who are Royalty Pharma's investors?
Royalty Pharma has 1 investor. Key investors include General Atlantic.
What is Royalty Pharma's ticker symbol?
The ticker symbol of Royalty Pharma is RPRX on NASDAQ.